Ponstel (mefenamic acid)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts